Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Polypeptide modulators of prostatic growth and development.

M T Story1

  • 1Department of Urology, Medical College of Wisconsin, Milwaukee 53226.

Cancer Surveys
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Opinions of Health Care Personnel Regarding Disincentives and Incentives for Living Kidney Donation at a Single Center.

Transplantation proceedings·2018
Same author

Home/family, peer, school, and neighborhood correlates of obesity in adolescents.

Obesity (Silver Spring, Md.)·2013
Same author

Relationships between vitamin and mineral supplement use, dietary intake, and dietary adequacy among adolescents.

Journal of the American Dietetic Association·2000
Same author

Characteristics of antigens from an HCG alpha secreting cell line (ElCo) derived from human breast carcinoma in a Native American patient.

American journal of obstetrics and gynecology·1997
Same author

Expression of transforming growth factor beta 1 (TGF beta 1), -beta 2, and- beta 3 by cultured human prostate cells.

Journal of cellular physiology·1996
Same author

Regulation of basic fibroblast growth factor expression by transforming growth factor beta in cultured human prostate stromal cells.

The Prostate·1996
Same journal

Future directions: bladder cancer.

Cancer surveys·2004
Same journal

Radiotherapy and chemotherapy for invasive bladder cancer.

Cancer surveys·2004
Same journal

The role of surgery in the multimodality treatment of bladder cancer.

Cancer surveys·2004
Same journal

Clonal development of bladder cancer and its relevance to the clinical potential of HLA antigen and TP53 based gene therapy.

Cancer surveys·2004
Same journal

Clinical evaluation of immunotherapy: are there differences between papillary and flat in situ bladder cancer?

Cancer surveys·2004
Same journal

Molecular biological changes in bladder cancer.

Cancer surveys·2004
See all related articles

Androgens influence prostate development, but other growth factors also play a role. These polypeptides, identified in the prostate, may regulate benign prostatic hyperplasia and prostate cancer.

Area of Science:

  • Urology
  • Endocrinology
  • Cell Biology

Background:

  • Androgens are key regulators of normal and abnormal prostate development.
  • Evidence suggests non-androgen substances also influence prostatic growth.

Purpose of the Study:

  • To identify and characterize polypeptides that influence prostate growth.
  • To explore the role of these factors in benign prostatic hyperplasia and prostate cancer.

Main Methods:

  • Identification of growth factors within the prostate.
  • Analysis of growth factor families including HBGF, TGF-beta, EGF, TGF-alpha, PDGF, NGF, and osteoblast growth factors.
  • Determination of cellular origin (stromal or epithelial) for growth factor synthesis and receptor presence.

Main Results:

Related Experiment Videos

  • Multiple polypeptide growth factors (e.g., HBGF, TGF-beta, EGF, PDGF) identified in the prostate.
  • Specific prostatic cell populations (stromal/epithelial) identified as sources of certain growth factors and their receptors.
  • Potential roles for these factors in regulating prostate growth pathways.

Conclusions:

  • Polypeptide growth factors are significant regulators of prostate development and disease.
  • Understanding these factors and their cellular interactions is crucial for targeting conditions like BPH and prostate cancer.